Search clinical trials for: Modulation of FiO2

Total 10000 results

Bayer

Completed

A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD). (BELUGA)

Neovascular Age-related Macular Degeneration

Belgium
Assiut University

Completed

Single Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery and HIPEC

Cytoreductive Surgery

Egypt
Massachusetts Eye and Ear Infirmary

Completed

Topical Avastin for Treatment of Corneal Neovascularization

Corneal Neovascularization

United States
German CLL Study Group
Celgene

Completed

A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy

Chronic Lymphocytic Leukemia

Germany
Incyte Corporation

Terminated

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

MPN (Myeloproliferative Neoplasms)

United States
Christian Candrian

Withdrawn

This is a Study to Verify if Tranexamic Acid Can Reduce the Anemia After a Femoral Shaft Fractures Surgery (ORL-ORT-023)

Femoral Shaft Fracture
AHEPA University Hospital

Completed

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization (LOW-RAO)

Arterial Occlusion

Greece
Bayer

Completed

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (AQUILA)

Macular Degeneration

Mexico, Argentina, Colombia, Costa Rica
Bayer

Completed

Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Macular Degeneration

Spain, Switzerland, Portugal, France, Canada, United Kingdom, Austria, Slovakia, Germany, Hungary, Italy, Lithuania, Czechia, Poland
Rijnstate Hospital

Completed

SuperB Trial: SUrgical Versus PERcutaneous Bypass (SuperB)

Cardiovascular Diseases

Netherlands
Opthea Limited

Completed

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Neovascular Age-related Macular Degeneration

United States, Czechia, France, Hungary, Israel, Italy, Latvia, Poland, Spain, United Kingdom
Retina Macula Institute

Completed

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Neovascular Age Related Macular Degeneration

United States
Qilu Hospital of Shandong University
Renmin Hospital of Wuhan University; Moriggia-Pelascini Gravedona Hospital

Completed

Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP)

Coronavirus Infections

China, Italy
Centro Nacional de Investigaciones Oncologicas...
Fundacion CRIS de Investigación para Vencer el Cáncer

Completed

Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer

Metastatic Breast Cancer | Bevacizumab-alone Maintenance Treatment Progression

Spain
Peking University Third Hospital
Huashan Hospital; Tianjin Medical University

Unknown

Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC (Rvision-001)

Stereotactic Body Radiation Therapy

China
Novartis Pharmaceuticals

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Japan
Fundación Pública Andaluza Progreso y Salud

Completed

Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery (TRA)

Osteoarthritis, Knee

Spain
Boehringer Ingelheim

Completed

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Carcinoma, Non-Small-Cell Lung

Spain, Bulgaria, Serbia, United Kingdom, United States, Korea, Republic of, Malaysia, Vietnam, Poland, Egypt, Hungary, Ukraine, Brazil, Turkey, Japan, Portugal, Thailand, Philippines, Russian Federation, Italy, Mexico, Greece, Croatia, Chi... and more
Bayer

Completed

An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies (GALAXY)

Macular Degeneration

Germany
University Hospital, Limoges

Completed

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea (BECONNEC)

Corneal Newvessels

France
Bayer
Regeneron Pharmaceuticals

Completed

Study for Collection of Aflibercept Data in Routine Practice (CODEX)

Eye Diseases

France
Allergan

Completed

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration

United States, Italy, Australia, Israel, Germany, Austria, France, Switzerland
Bayer
Regeneron Pharmaceuticals

Completed

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO) (JPMS-CRVO)

Retinal Vein Occlusion

Japan
University of Utah
Agency for Healthcare Research and Quality (AHRQ)

Completed

Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
Centre Hospitalier Universitaire, Amiens

Completed

Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol (ANTICONEURORAD)

Aneurysm

France
Daiichi Sankyo, Inc.

Completed

Study of DS-7080a for the Treatment of Macular Degeneration

Diabetic Macular Edema | Neovascular Age-Related Macular Degeneration

United States
McMaster University
Canadian Institutes of Health Research (CIHR)

Unknown

Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing

Foot Ulcer, Diabetic | Venous Ulcer

Canada
Assiut University

Unknown

Regisry of the Stroke Patients in Assiut University Hospital

All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
Amgen

Terminated

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
San Ni Chen

Completed

Refractive Error and Biometry in Retinopathy of Prematurity

Retinopathy of Prematurity
Bayer
Regeneron Pharmaceuticals

Completed

Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients (VEGA)

Glaucoma, Neovascular

Japan
RenJi Hospital

Completed

EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction (EARLY-MYO)

Acute ST-segment Elevation Myocardial Infarction

China
Central Hospital, Nancy, France

Terminated

Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke (THRACE)

Cerebrovascular Accident | Cerebral Stroke

France
St. Jude Children's Research Hospital

No longer available

Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver

Hepatic Veno-occlusive Disease

United States
Adiyaman University Research Hospital

Unknown

The Effect of Heparinization Due to LBW (LBWH)

Bleeding | Heparin | Heparin Overdose
Bayer
Regeneron Pharmaceuticals

Completed

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Diabetic Macular Edema (DME) | Age-related Macular Degeneration (AMD) | Central Retinal Vein Occlusion (CRVO)

Canada
University Medical Center Groningen
Martini Hospital Groningen

Completed

Fluorescence Guided Surgery in Breast Cancer (MARGIN)

Breast Cancer

Netherlands
The Catholic University of Korea

Unknown

Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Venous Thromboembolism

Korea, Republic of
Groupe Francophone des Myelodysplasies
Roche Pharma AG; Celgene

Completed

Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.

Myelodysplastic Syndromes

France, Monaco
Biocad

Completed

A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries

Deep Vein Thrombosis

Russian Federation
Dr. Yoo-Joung Ko
Roche Pharma AG

Completed

Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis (SBRT-Avastin)

Colorectal Cancer.

Canada
Talkha Central Hospital

Completed

Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section

Postpartum Hemorrhage | Hemorrhage of Cesarean Section and/or Perineal Wound | Uterine Atony

Egypt
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Veno-occlusive Disease

United States, Canada
University Health Network, Toronto
Celgene

Terminated

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) (Rev-CLL)

Chronic Lymphocytic Leukaemia

Canada
Weill Medical College of Cornell University

Withdrawn

Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS) (VEGF-ARDS)

Acute Respiratory Distress Syndrome | Severe Sepsis

United States
Biocad

Withdrawn

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
University of Campania "Luigi Vanvitelli"

Completed

Intravitreal Bevacizumab in Agioid Streaks

Choroidal Neovascularization | Angioid Streaks

Italy
Hospital de Clinicas de Porto Alegre

Withdrawn

Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

Stroke

Brazil
Academisch Medisch Centrum - Universiteit van Amsterdam...
Radboud University Medical Center; University Medical Center Groningen; UMC Utrecht and other collaborators

Unknown

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) (BRVO)

Retinal Vein Occlusion

Netherlands
Sion Microtec Ltd.

Unknown

Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze

Bleeding | Coagulopathy

Israel

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations